Effects of Reconstituted High-Density Lipoprotein Infusions on Coronary AtherosclerosisA Randomized Controlled Trial
Top Cited Papers
Open Access
- 18 April 2007
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 297 (15), 1675-1682
- https://doi.org/10.1001/jama.297.15.jpc70004
Abstract
Despite highly effective contemporary treatment regimens, the majority of vascular events are not prevented, particularly in high-risk individuals.1,2 Therefore, further strategies to decrease atherosclerosis burden and improve cardiovascular outcomes are needed. There is a strong inverse association between high-density lipoprotein (HDL) cholesterol and risk of coronary heart disease in epidemiological studies.3,4Keywords
This publication has 19 references indexed in Scilit:
- Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic LesionsCirculation, 2004
- Restoration of Endothelial Function by Increasing High-Density Lipoprotein in Subjects With Isolated Low High-Density LipoproteinCirculation, 2003
- Effects of AGI-1067 and Probucol After Percutaneous Coronary InterventionsCirculation, 2003
- High-Density Lipoprotein Restores Endothelial Function in Hypercholesterolemic MenCirculation, 2002
- High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from framingham to the veterans affairs high-density lipoprotein intervention trialThe American Journal of Cardiology, 2000
- Effects of Probucol on Vascular Remodeling After Coronary AngioplastyCirculation, 1999
- Probucol and Multivitamins in the Prevention of Restenosis after Coronary AngioplastyNew England Journal of Medicine, 1997
- Production and Characterization of a Reconstituted High Density Lipoprotein for Therapeutic ApplicationsVox Sanguinis, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- High density lipoprotein as a protective factor against coronary heart disease. The Framingham studyAmerican Journal Of Medicine, 1977